Stay informed with the latest litigation news. Explore now

Viiv Healthcare competitive analysis

Latest publications and patents of Viiv Healthcare New

Explore the latest publications and patents granted to Viiv Healthcare, showcasing their recent innovations and technological advancements.

Last updated on: Sep 9, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Viiv Healthcare

Dec 13, 2023Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionGranted And Under Opposition
Feb 15, 2023Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory ActivityPatent Maintained As Amended
Jun 5, 2019Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory ActivityOpposition Rejected
Aug 22, 2018Antiviral TherapyOpposition Rejected
Mar 21, 2018Antiviral TherapyRevoked

Explore Viiv Healthcare's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 11, 2025
Patent NumberGrant DateTitleTotal Oppositions
Dec 13, 2023Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv Infection9
Feb 15, 2023Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory Activity1
Jun 5, 2019Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory Activity1
Aug 22, 2018Antiviral Therapy4
Mar 21, 2018Antiviral Therapy2

Latest PTAB cases involving Viiv Healthcare New

Discover the latest PTAB cases involving Viiv Healthcare, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 15, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Viiv Healthcare

IPR2015-00550Jan 8, 2015TEVA PHARMACEUTICALS USAVIIV HEALTHCAREInstitution Denied
IPR2014-00876Jun 2, 2014APOTEXVIIV HEALTHCARETerminated-Settled

Top competitors of Viiv Healthcare

Top competitors of Viiv Healthcare based on patent oppositions.